InvestorsHub Logo
icon url

roger that

03/03/16 12:56 PM

#18604 RE: proftstocksny2 #18602

It may actually becoma a longer term player the way the demographics of hospital expenditures is being directed by gub towards that end to this point the thing that matters are the patents,nobody seems to notice that we have have recently added to that portfolio and the patents also represent a large Trump card in that the projected molecular diagnosis market is 7.1 Billion US dollars That' on the books s a lot of black
icon url

rachelsdaddy

03/03/16 1:00 PM

#18605 RE: proftstocksny2 #18602

Only if the mm's let it.
icon url

koen2

03/03/16 1:11 PM

#18607 RE: proftstocksny2 #18602

Be aware of things.

Today we broke to the downside.
stoploss triggered for half my position.

i'm not planning to add.(not even at $0.15 or lower.
Even a FDA clearence is not going to take us far.$0.27 max.

So get Lucky and hoping for it before 24march and dont be greedy.

Just saying.only my opinion
This stock is not a fairytale.
Its just endless dilution for another 3 years.

Lowered my target to $0.25.

Gltya



icon url

yesterdaysnews74

03/03/16 1:30 PM

#18613 RE: proftstocksny2 #18602

FDA approval won't be there until late September at the earliest I expect!